Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Lipid Emulsion [EPC]
Ononis Spinosa Whole, derived from the Restharrow plant, is a botanical extract utilized primarily as a Non-Standardized Plant Allergenic Extract for diagnostic and therapeutic purposes in immunology. It is also classified within Lipid Emulsion contexts for specific clinical formulations.
Name
Ononis Spinosa Whole
Raw Name
ONONIS SPINOSA WHOLE
Category
Lipid Emulsion [EPC]
Drug Count
8
Variant Count
8
Last Verified
February 17, 2026
About Ononis Spinosa Whole
Ononis Spinosa Whole, derived from the Restharrow plant, is a botanical extract utilized primarily as a Non-Standardized Plant Allergenic Extract for diagnostic and therapeutic purposes in immunology. It is also classified within Lipid Emulsion contexts for specific clinical formulations.
Detailed information about Ononis Spinosa Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Ononis Spinosa Whole.
Ononis Spinosa Whole, commonly known as Restharrow, is a botanical substance derived from the entire plant of Ononis spinosa, a perennial shrub belonging to the Fabaceae (legume) family. In the context of modern clinical pharmacology, Ononis Spinosa Whole is categorized under several Established Pharmacologic Classes (EPC), most notably as a Non-Standardized Plant Allergenic Extract [EPC] and, in specific pharmaceutical preparations, a Lipid Emulsion [EPC]. While traditionally recognized in European herbal medicine for its diuretic properties, its primary role in contemporary regulated medicine involves its use in the diagnosis and treatment of Type I hypersensitivity reactions (allergies).
As an allergenic extract, Ononis Spinosa Whole contains a complex mixture of proteins, glycoproteins, and polysaccharides that are indigenous to the plant. When introduced to a sensitized individual, these components interact with specific immunoglobulin E (IgE) antibodies bound to mast cells and basophils. This interaction triggers the release of inflammatory mediators, such as histamine, which allows clinicians to confirm a patient's sensitivity to this specific botanical allergen through skin prick testing or intradermal testing. According to the FDA’s Structured Product Labeling (SPL) standards, this substance is also linked to classifications involving standardized insect venoms and chemical allergens, reflecting its broad utility in specialized immunological diagnostic kits.
The mechanism of action for Ononis Spinosa Whole depends entirely on its clinical application. When used as a diagnostic tool for allergies, it operates via an immunological challenge. Upon administration into the epidermis or dermis, the allergenic proteins in the extract cross-link IgE antibodies on the surface of mast cells. This cross-linking results in degranulation, releasing histamine, leukotrienes, and prostaglandins. The visible result is a 'wheal and flare' reaction—a localized swelling and redness that peaks within 15 to 20 minutes. This provides a direct, observable measurement of a patient's allergic sensitization.
In its traditional or supportive role (often referenced in European Pharmacopoeia), Ononis spinosa is thought to exert a mild aquaretic effect. This is attributed to its flavonoid content (such as ononin) and essential oils. Unlike loop diuretics that interfere with ion transport, aquaretics like Restharrow are believed to increase water excretion without significantly altering electrolyte balance, primarily by increasing renal blood flow and glomerular filtration rate. However, it is critical to note that for FDA-listed products, the allergenic and diagnostic mechanisms are the primary focus of clinical regulation.
The pharmacokinetics of Ononis Spinosa Whole differ significantly from conventional systemic drugs because it is typically administered locally (topically or intradermally) rather than orally for its allergenic effects.
Ononis Spinosa Whole is utilized in several specific clinical scenarios:
Ononis Spinosa Whole is available in the following formats:
> Important: Only your healthcare provider can determine if Ononis Spinosa Whole is right for your specific condition. The use of allergenic extracts must be conducted under the supervision of a trained allergist or immunologist.
Dosage for Ononis Spinosa Whole is highly individualized and depends on the method of administration. For Skin Prick Testing (SPT), a single drop of the extract (typically 1:20 w/v) is applied to the forearm or back, and the skin is pricked through the drop. For Intradermal Testing, a much more dilute solution (often 1:1000 to 1:100 w/v) is used, and approximately 0.02 mL is injected to create a small bleb.
In the context of traditional oral use (where permitted), a common dose is 2 to 3 grams of the dried herb steeped in boiling water, taken 2 to 3 times daily. However, this is not a standardized FDA-approved dosage and should be discussed with a healthcare provider.
Ononis Spinosa Whole extracts are used in pediatric populations for allergy diagnosis. The procedure is identical to adult testing, though the number of simultaneous tests may be limited to reduce patient distress. There is no established 'safe dose' for oral consumption of Ononis spinosa in children, and it is generally avoided in pediatric populations due to a lack of safety data regarding its effects on growth and development.
For diagnostic testing, no dosage adjustment is required as systemic absorption is minimal. For oral use as a diuretic, Ononis Spinosa Whole is contraindicated in patients with impaired renal function resulting from heart or kidney failure (edema management requires more potent, regulated diuretics).
No specific adjustments are documented for allergenic testing. Patients with severe liver disease should be monitored for any unusual systemic reactions if immunotherapy is being considered.
Elderly patients may have reduced skin reactivity (delayed or diminished wheal response). Clinical interpretation of skin tests in patients over 65 should account for age-related skin changes. No specific dosage adjustment is usually necessary, but caution is advised in patients with underlying cardiovascular disease.
As a diagnostic agent, Ononis Spinosa Whole is administered exclusively by healthcare professionals.
In a diagnostic setting, a missed appointment simply requires rescheduling. If undergoing immunotherapy, a missed dose may require a 'step-back' in dosage concentration to ensure safety and prevent anaphylaxis upon the next administration. Consult your allergist immediately if a scheduled injection is missed.
An 'overdose' of Ononis Spinosa Whole typically manifests as a systemic allergic reaction (anaphylaxis).
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to self-administer allergenic extracts without medical guidance.
The most frequent side effects associated with Ononis Spinosa Whole are localized to the site of administration. During diagnostic testing, nearly all sensitized patients will experience:
These reactions are expected and indicate a positive test result rather than an adverse event in the traditional sense.
> Warning: Stop taking Ononis Spinosa Whole and call your doctor immediately if you experience any of these symptoms of anaphylaxis:
There are no known long-term side effects associated with the occasional use of Ononis Spinosa Whole for diagnostic purposes. In the context of long-term immunotherapy, some patients may develop 'serum sickness-like' symptoms, including joint pain and fever, though this is exceedingly rare with plant-based extracts compared to animal-derived sera.
While Ononis Spinosa Whole itself may not always carry a specific individual black box warning, the class of Allergenic Extracts often carries a general FDA warning regarding the risk of severe non-fatal and fatal systemic reactions.
Summary of Warning: Allergenic extracts should only be administered by physicians who are exceptionally experienced in the treatment of anaphylaxis. Patients must be observed for at least 30 minutes. Epinephrine must be immediately available. Patients with unstable asthma or those taking beta-blockers may be at increased risk for severe outcomes.
Report any unusual symptoms to your healthcare provider. Your safety depends on accurate reporting of previous allergic reactions.
Ononis Spinosa Whole must be used with extreme caution. Because it is designed to elicit an immune response, there is always an inherent risk of that response becoming systemic and life-threatening. Patients must provide a full medical history, specifically highlighting any previous history of severe asthma or prior reactions to skin testing.
No specific FDA black box warning exists uniquely for Ononis Spinosa Whole as a single agent, but it falls under the collective warning for Non-Standardized Plant Allergenic Extracts. This warning emphasizes that systemic reactions can occur, ranging from mild hives to fatal anaphylaxis. The extract must be administered in a facility equipped with emergency resuscitative equipment.
Generally, Ononis Spinosa Whole does not affect the ability to drive. However, if a patient experiences a vasovagal response (fainting) or a mild systemic reaction requiring medication, they should not drive until they are fully recovered and cleared by a clinician.
Alcohol should be avoided for 24 hours before and after testing. Alcohol can increase peripheral vasodilation, which may exacerbate the 'flare' reaction or, in rare cases, lower the threshold for a systemic allergic response.
For diagnostic testing, there is no withdrawal syndrome. For immunotherapy, discontinuation will result in a gradual return of the patient's original allergy symptoms when exposed to the plant in the environment.
> Important: Discuss all your medical conditions with your healthcare provider before starting Ononis Spinosa Whole. Ensure they are aware of any history of fainting or severe allergies.
Ononis Spinosa Whole does not typically interfere with standard blood chemistry or hematology panels. However, it will interfere with Skin Sensitivity Tests for other allergens if the reactions are so large that they overlap on the skin. It also renders Serum IgE testing for this specific plant redundant if the skin test is already positive.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for your safety during allergy testing.
Ononis Spinosa Whole must NEVER be used in the following circumstances:
Patients allergic to other members of the Fabaceae family (such as peanuts, soy, lentils, or clover) may show cross-reactivity to Ononis Spinosa Whole. Clinicians should be prepared for a more robust reaction in these individuals.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing or administering Ononis Spinosa Whole.
Ononis Spinosa Whole is classified as Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have not been conducted. The primary risk is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis) in the mother. Anaphylaxis can lead to maternal hypotension, which significantly reduces placental blood flow and can cause fetal hypoxia, preterm labor, or fetal death. Diagnostic testing is generally deferred until postpartum unless the information is critical for immediate management.
It is unknown whether the components of Ononis Spinosa Whole are excreted in human milk. Because most allergenic proteins are large molecules and are administered in minute quantities for testing, systemic absorption is low. However, caution should be exercised. There is no data on the effects of this extract on the nursing infant or on milk production.
Safety and effectiveness in children under the age of 5 have not been extensively established for all forms of allergenic extracts. While skin testing is performed in infants and toddlers, the risk of systemic reactions may be harder to monitor as young children cannot articulate early symptoms like throat itching or chest tightness. Pediatric dosing is based on skin surface area and the clinical judgment of the allergist.
Clinical studies of Ononis Spinosa Whole did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. It is known that skin reactivity decreases with age. Furthermore, elderly patients are more likely to have comorbid cardiovascular conditions or be taking medications like beta-blockers that increase the risk associated with allergic reactions.
For diagnostic use, renal impairment does not significantly affect the safety or efficacy of the test. For traditional oral use, Ononis spinosa is contraindicated in patients with edema caused by impaired cardiac or renal function, as it may delay necessary conventional treatment.
There are no specific guidelines for the use of Ononis Spinosa Whole in patients with hepatic impairment. Systemic metabolism of the trace amounts of flavonoids absorbed during a skin test is unlikely to be affected by liver disease.
> Important: Special populations require individualized medical assessment. Always inform your specialist of your pregnancy or nursing status.
Ononis Spinosa Whole acts as an immunological agonist at the level of the IgE-mast cell interface. The primary active constituents are the plant-derived proteins and glycoproteins. In a sensitized individual, these proteins possess epitopes that bind to the Fab portion of IgE antibodies. When two or more IgE antibodies are cross-linked by a single allergen molecule, it triggers a signal transduction cascade involving tyrosine kinases (such as Syk and Lyn). This leads to the influx of calcium ions and the subsequent degranulation of the mast cell, releasing pre-formed mediators like histamine and synthesizing new mediators like leukotrienes.
The pharmacodynamic response is measured by the Wheal and Flare reaction.
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Local) |
| Protein Binding | High (to IgE in tissues) |
| Half-life | 2–4 hours (local tissue residence) |
| Tmax | 15–20 minutes (for skin reaction) |
| Metabolism | Local Proteolysis |
| Excretion | Renal (trace metabolites) |
Ononis Spinosa Whole contains several classes of bioactive compounds:
It is classified as a Non-Standardized Plant Allergenic Extract [EPC]. It shares clinical characteristics with other botanical extracts like Ragweed or Timothy Grass extracts, though its specific protein profile is unique to the Ononis genus.
Common questions about Ononis Spinosa Whole
Ononis Spinosa Whole is primarily used as a diagnostic tool in the field of allergy and immunology. It is prepared as an extract to help doctors identify if a patient has a specific allergy to the Restharrow plant through skin testing. When a small amount is applied to the skin, it triggers a localized reaction in allergic individuals, allowing for a clear diagnosis. Additionally, it has historical uses in traditional medicine as a mild diuretic to support urinary tract health. However, its most common clinical use today is for identifying environmental sensitivities.
The most common side effects are localized to the area where the extract was applied or injected. These include intense itching, redness (a flare), and a raised, pale bump (a wheal) that looks like a hive. These reactions are actually the intended result of an allergy test and usually fade within a few hours. Some patients may also experience a 'late-phase' reaction where the area becomes slightly swollen or red again several hours later. Systemic side effects are rare but can include generalized hives or, in very rare cases, a severe allergic reaction.
It is generally advised to avoid alcohol for at least 24 hours before and after receiving an Ononis Spinosa Whole skin test. Alcohol can cause your blood vessels to dilate, which might make a skin reaction appear larger or more severe than it actually is, leading to an inaccurate test result. Furthermore, alcohol can sometimes increase the risk of a systemic allergic reaction in highly sensitive people. Always follow the specific pre-test instructions provided by your allergist. If you have consumed alcohol recently, be sure to inform your healthcare provider before the procedure begins.
The use of Ononis Spinosa Whole during pregnancy is generally avoided unless the diagnostic information is absolutely necessary for the mother's health. While the extract itself is not known to be toxic to the fetus, the risk of a systemic allergic reaction (anaphylaxis) poses a significant danger. Anaphylaxis can cause a dangerous drop in the mother's blood pressure, which can cut off oxygen to the baby. Most doctors prefer to wait until after delivery to perform allergy testing. If you are pregnant or planning to become pregnant, discuss the risks and benefits with your specialist.
When used for allergy testing, Ononis Spinosa Whole works very quickly. A localized skin reaction typically begins to appear within 5 to 10 minutes of the skin being pricked or injected. The reaction usually reaches its maximum size (the 'peak') between 15 and 20 minutes. This rapid onset allows doctors to provide test results during the same office visit. If you do not show a reaction within 20 minutes, the test is usually considered negative for that specific allergen.
Since Ononis Spinosa Whole is typically used as a one-time diagnostic test, there is no need to 'taper' off the medication. You do not 'take' it in the way you would a daily pill. However, if you are receiving it as part of a long-term immunotherapy program (allergy shots), stopping suddenly will mean you lose the protection or desensitization the shots were providing. Your allergy symptoms would likely return when you are exposed to the plant in nature. Always consult your allergist before changing or stopping an immunotherapy schedule.
If you miss an appointment for an allergy test involving Ononis Spinosa Whole, you simply need to reschedule with your doctor's office. There are no health consequences to missing a diagnostic test other than a delay in finding out what you are allergic to. If you are on an immunotherapy (allergy shot) schedule and miss a dose, contact your clinic immediately. They may need to adjust your next dose to a slightly lower concentration to ensure you don't have a reaction after the gap in treatment.
There is no evidence to suggest that Ononis Spinosa Whole causes weight gain. It is not a hormonal medication or a metabolic stimulant. When used as a diagnostic skin test, the amount of the extract that enters your system is extremely small—far too little to affect your weight or metabolism. Even in traditional oral forms used as a diuretic, the effect is to temporarily increase water loss, which might actually cause a very slight, temporary decrease in water weight, but it does not affect body fat.
Ononis Spinosa Whole can interact with several types of medications, particularly those that affect your immune response or your body's ability to handle an allergic reaction. Antihistamines are the most common concern, as they can block the test from working and must be stopped days in advance. More seriously, beta-blockers used for heart conditions can make an allergic reaction much harder to treat. You must provide your doctor with a full list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking before the test.
Ononis Spinosa Whole is a botanical extract rather than a synthetic drug, so the concept of 'generic' vs. 'brand name' is slightly different. It is produced by various specialized laboratories that create allergenic extracts. While there may be different manufacturers, the extract is generally referred to by its scientific name, *Ononis spinosa*. Because these are non-standardized extracts, one manufacturer's version may differ slightly in potency from another's, so allergists often prefer to stick with a single trusted supplier for consistent results.